PTPRK and malignant colon neoplasm: Thus, this is suggestive that forced depletion of PTPRK contributes to the aggressive properties of CD133‐positive colon cancer cells through the potentiation of the pro‐oncogenic CD133–AKT pathway (Fig. 6).